Biomarker for Diagnosis and Monitoring of Treatment Response in Major Depressive Disorder: Changes in Serum L‐Glutamine Levels

Documenti analoghi

• Targeted LC–MS/MS‐Based Serum Nucleoside Metabolomics for Early Detection and Biomarker Discovery in Colorectal Cancer
  di: Ramzy Rashed, et al.
  Pubblicazione: (2026)
• Method Validation for the Determination of Nicotine and Nicotine Metabolite Levels in Urine, Serum, and Saliva Samples
  di: Gülsüm Abuşoğlu, et al.
  Pubblicazione: (2025)
• Screening and Validation Serum Potential Biomarkers for Intrahepatic Cholestasis of Pregnancy Comparison to Healthy Controls by 1H‐NMR and UPLC–MS/MS
  di: Yufeng Deng, et al.
  Pubblicazione: (2025)
• Integrating Serum Pharmacochemistry With Network Pharmacology to Elucidate the Mechanism of Wushen Decoction in the Prevention and Treatment of Lower Extremity Erysipelas
  di: Ying Wang, et al.
  Pubblicazione: (2025)
• Insights Into the Mechanism of Treatment of Ulcerative Colitis With Preprocessed and Postprocessed Dried Ginger by Integrating Serum Pharmacochemistry With Network Pharmacology and Harmacological Validation
  di: Siming Han, et al.
  Pubblicazione: (2025)